Perrigo | PRGO - Operating Expenses


Perrigo reported $961.4M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
AbbVie USD 10.52B 258M Sep/2026
Abbott USD 11.66B 1.2B Sep/2026
Bayer EUR 9.92B 121M Sep/2026
Bristol-Myers Squibb USD 23.4B 1.08B Sep/2026
Coherus Biosciences USD 51.83M 2.48M Dec/2025
Corcept Therapeutics USD 225.75M 10.9M Sep/2026
Dr.Reddys Laboratories INR 74.82B 2.93B Sep/2026
Eli Lilly USD 10.52B 496M Jun/2026
J&J USD 18.93B 1.09B Sep/2026
Merck USD 10.75B 5.02B Sep/2026
Nestle CHF 36.13B 2.29B Jun/2026
Pacira USD 1.18B 995.96M Sep/2026
Perrigo USD 961.4M 670.9M Sep/2026
Pfizer USD 89B 3.81B Sep/2026
Phibro Animal Health USD 417.67M 1.04B Sep/2026
Prestige Brands USD 213.19M 7.06M Jun/2026
Reckitt Benckiser GBP 6.26B 3.51B Dec/2024
Sanofi EUR 10.51B 598M Sep/2026
Supernus Pharmaceuticals USD 1.06B 31.25M Sep/2026
Teva Pharmaceutical Industries USD 3.18B 733M Sep/2026
Xeris Pharmaceuticals USD 86.93M 11.72M Jun/2026
Zoetis USD 3.3B 155M Sep/2026